Global Recombinant Proteins Market Size, Share & Industry Trends Analysis Report By Product, By End User, By Application (Drug Discovery & Development, Academic Research Studies, Biopharmaceutical Production, Diagnostics, Biotechnology Research), By Regional Outlook and Forecast, 2022 - 2028

The Global Recombinant Proteins Market size is expected to reach $2.6 billion by 2028, rising at a market growth of 10.8% CAGR during the forecast period.

Recombinant proteins have a huge future in the study and development of cancer therapies. Examples of recombinant proteins used in cancer therapy research include growth factors, immunological checkpoints, and cell damage & oxidative stress proteins (preclinical stage). The utilization of recombinant proteins including immunological checkpoint, antibodies, and growth factors, for targeted purposes has risen because of a greater knowledge of neoplastic signalling cascades and the proteins involved in them.

Researchers utilise these proteins frequently to study how cancer signalling pathways and functions. Research uses recombinant immune checkpoints that directly target programmed death-1 (PD-1) and programmed death ligand-1 and 2 (PD-L1), including PD-1/PD-L1 Inhibitor 1 and PD-1/PD-L1 Inhibitor 2. Aside from that, proteins like CD40 Ligand/TRAP, CD226, and Human CellExp CTLA4/CD152 are often employed in studies on cancer therapy.

Growth in the business is predicted to be fueled by the increased incidence of chronic disorders such granulomatous disease, haemophilia, and sclerosis. Additionally, improved recombinant protein products, the growing preference for biologics and biosimilars, and other reasons all contribute to the industry's expansion. The race to discover cures and diagnostic tools for the SARS-CoV2 virus was fuelled by the COVID-19 epidemic.

With over 400 million people worldwide suffer from uncommon genetic illnesses, according to Global Genes. This figure demonstrates the urgent need for therapies, an improvement in healthcare environments, and increased public knowledge of health issues. A critical instrument for the creation of medicines is the requirement for cutting-edge research and knowledge of drug targeting mechanisms.

Cohort programmes have helped several regions create biobanks that give researchers access to high-quality samples that will revolutionise treatment efforts. This may lead to a greater emphasis on the identification of biomarkers for various illnesses. As an illustration, the FDA approved Ayvakit in August 2022 to address advanced systemic mastocytosis, a rare blood disorder.

COVID-19 Impact Analysis

The requirement for the COVID-19 vaccine to be developed quickly and on a large scale, as well as its ongoing commercial manufacturing activities, had a favourable effect on the development of biologics-based research initiatives and ultimately helped the industry's expansion. The COVID-19 pandemic had a favourable effect on the expansion of the proteins market. Recombinant protein vaccines may be developed with a combination of subunits of different adjuvants and antigens that will be more effective against SARS-CoV-2 infections and be readily available in the centre, it was suggested in light of the growth in COVID infection.

Market Growth Factors

Growing Emphasis On Customized Medicine Due To An Increase In The Prevalence Of Chronic Diseases

The market for recombinant proteins is anticipated to expand in demand due to the increased research and development on biologics. The R&D industry has traditionally required a lot of capital because of lengthy study periods and regulatory delays. Consumption on R&D accounts for a considerable share of global spending. Governments acknowledge R&D as a crucial factor in a nation's development, global competitiveness, and public good. R&D funding and spending have risen steadily as a result.

Increasing Biologics Research And Development

Semiconductor electronic devices are usually covered with a protective enclosure to surround the internal components and protect them from any adverse condition. These enclosures are created based on different fabrication methods to form a final product in a single sheet, preferably made of aluminum alloys. Anodic Aluminum Oxide-nanopores (AAO-np) structures fabricated on the aluminum alloy using a two-step anodizing process are known to exhibit good crystallinity with an oxide layer.

Market Restraining Factor

Recombinant proteins are getting cheaper

Recombinant proteins are made in labs using cells that have been grown, which contributes to their expensive price. Purification of these medications, which can make up as much as 80% of the manufacturing costs, is one of the major expenses. Price erosion is defined as when many players enter a particular market and sell identical products without any uniqueness, saturating the market with less creative and reasonably priced goods. Price erosion is the constant drop in the price of these products in each market, which slows down market expansion.

Product Outlook

Based on Product, the market for recombinant proteins is classified into growth factors and chemokines, immune response proteins, structural proteins, membrane proteins, kinase proteins, regulatory proteins, recombinant metabolic enzymes, adhesion molecules and receptors, and other recombinant proteins. Immune response proteins are expected to command a sizable sales share in 2021. A crucial group of proteins in the body are cytokines. These little proteins act as immune system messengers. They serve as the immune system's network of communication and are created in reaction to a threat. Immune system cells can sometimes interact by touching one another directly, but more frequently, they do so via secreting cytokines, which can operate on other cells nearby or far away.

Application Outlook

Based on application, the market Drug Discovery & Development, Biopharmaceutical Production, Biotechnology Research, Academic Research Studies, Diagnostics, and Other Applications. The biotechnology research command a significant revenue share in 2021. Recombinant proteins aid in illuminating an organism's basic and underlying principles. These molecules can be used to identify and pinpoint the location of the protein that a particular gene encodes, as well as to learn more about how other genes are involved in processes such as cell signalling, metabolism, growth, replication, and death, as well as translation, transcription, and protein modification.

End User Outlook

Based on End User, the Recombinant Proteins Market is divided in pharmaceutical and biopharmaceutical industry, biotechnology industry, academic research institutes, contract research organisations, and other end users. Contract Research Organizations are expected to account for a sizable portion of market revenue in 2021. The R&D industry saw increased investments in regards to partnerships and collaborations between academic institutions and businesses. For instance, the Center for Therapeutic Innovation (CTI) at Pfizer serves as a forum for interaction among stakeholders in the healthcare system.

Recombinant Proteins Market Report Coverage

Report Attribute	Details
Market size value in 2021	USD 1.2 Billion
Market size forecast in 2028	USD 2.6 Billion
Base Year	2021
Historical Period	2018 to 2020
Forecast Period	2022 to 2028
Revenue Growth Rate	CAGR of 10.8% from 2022 to 2028
Number of Pages	283
Number of Tables	440
Report coverage	Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Companies Strategic Developments, Company Profiling
Segments covered	Product, Application, End User, Region
Country scope	US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria
Growth Drivers	Growing Emphasis On Customised Medicine Due To An Increase In The Prevalence Of Chronic Diseases Increasing Biologics Research And Development
Restraints	Recombinant proteins are getting cheaper

Regional Outlook

Based on geography, the Recombinant Proteins Market is classified into North America, Europe, Asia Pacific, and LAMEA. The leading regional market for recombinant proteins in 2021 was North America. The high prevalence of chronic and genetic diseases, the availability of funding for R&D, government initiatives for R&D in the pharmaceutical industry, the growing use of life science techniques in research and academia, the significant presence of major pharmaceutical and biotechnology organizations, and the application of analytical instruments in drug discovery and development are all factors that contribute to North America holding a significant share of the global market.

Free Valuable Insights: Global Recombinant Proteins Market size to reach USD 2.6 Billion by 2028

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bio-Techne Corporation, Thermo Fisher Scientific, Inc., Merck Group, Bio-Rad Laboratories, Inc., Abcam plc, Genscript Biotech Corporation, Miltenyi Biotec B.V. & Co. KG, Proteintech Group, Inc., BPS Bioscience, Inc., and RayBiotech Life, Inc.

Strategies deployed in Recombinant Proteins Market

• Nov-2022: Abcam comes into agreement with NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research. Through this agreement, Abcam RabMAb™ recombinant antibodies would be produced as part of the first 64-plex protein panel for NanoString’s CosMx™ Spatial Molecular Imager (SMI). Additionally, this agreement would open the full capability of spatial biology and help enhance care for people with cancer.
• 2022-Jul: Bio-Rad Laboratories launched EconoFit Columns, a low-pressure prepacked chromatography column pack. The EconoFit columns are created for resin screening, enabling customers that are designing protein purification workflows to choose the optimal chemistry for various targets. The products offer run-to-run uniformity to support preparative scale purifications and method advancement for the latest target proteins, as well as to improve existing workflows.
• Feb-2022: Abcam came into agreement with Twist Bioscience Corporation, a synthetic biology company. Under this agreement, Abcam would use a proprietary Twist VHH phage library for antibody development, discovery, and commercialization for research and diagnostic application. Moreover, Twist Bioscience grants Abcam the right to perform research and development activities utilizing Twist single domain (VHH) synthetic antibody library.
• Jan-2022: Thermo Fisher Scientific Inc. completed the acquisition PeproTech, Inc., a leading developer, and manufacturer of recombinant proteins. Through this acquisition, PeproTech's recombinant proteins suite aligns with Thermo Fisher's cell culture media products and would allow Thermo Fisher to offer customers significant advantages through an integrated offering.
• 2021-Nov: Abcam partnered with Nautilus Biotechnology, Inc., a development-stage life sciences company. Under this partnership, Both companies would focus on the combined advancement of affinity binding reagents used on the Nautilus proteomic analysis system and would broaden in the upcoming time to the large-scale manufacturing and supply of reagents for production.
• Mar-2021: Bio-Techne Corporation released Cultrex™ UltiMatrix, a hydrogel extracellular matrix that is beneficial for cultivating pluripotent stem cells and organoids in terms of performance and consistency. The product develops Matriz hydrogels that support the growth use of pluripotent stem and organoid cells for drug research, commercialize medicine, and regenerative medicine.
• Nov-2020: Merck signed an agreement with Donghao Lansheng (Group) Co., Ltd., a large modern service industry. This agreement would drive a new process that helps the custom clearing of research material for analytical use and biomedical innovation, through this Merck would be able to process shipments with the technical dossier and fewer application needs.
• Nov-2019: Abcam plc announced a partnership with BrickBio, a Tiger Gene suite company and have specialization in site-specific protein modification. Through this partnership, Abcam would have full rights to the platform for the formation of novel conjugation-ready recombinant products for the research equipment market and to produce the platform over its recombinant antibody and protein offering for diagnostic use.
• Apr-2019: Bio-Techne Corporation Collaborated with Elpiscience BioPharma, a clinical-stage biopharmaceutical company. Through this collaboration, both companies aimed to advance anti-cancer therapeutics and boost the development of the latest biologics to meet the medical requirements in Oncology.
• Apr-2018: Proteintech Group acquired HumanZyme, a manufacturer of recombinant human proteins. Through this acquisition, the company would strengthen its place as a manufacturer of antibodies, ELISA kits, and proteins.

Scope of the Study

Market Segments Covered in the Report:

By Product

• Growth Factors & Chemokines
• Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors
• Structural Proteins
• Membrane Proteins
• Kinase Proteins & Regulatory Proteins
• Immune Response Proteins
• Others

By End User

• Pharmaceutical & Biopharmaceutical Companies
• Biotechnology Companies
• Academic Research Institutes
• Contract Research Organizations
• Others

By Application

• Drug Discovery & Development
• Academic Research Studies
• Biopharmaceutical Production
• Diagnostics
• Biotechnology Research
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• Bio-Techne Corporation
• Thermo Fisher Scientific, Inc.
• Merck Group
• Bio-Rad Laboratories, Inc.
• Abcam plc
• Genscript Biotech Corporation
• Miltenyi Biotec B.V. & Co. KG
• Proteintech Group, Inc.
• BPS Bioscience, Inc.
• RayBiotech Life, Inc.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Recombinant Proteins Market, by Product
1.4.2 Global Recombinant Proteins Market, by End User
1.4.3 Global Recombinant Proteins Market, by Application
1.4.4 Global Recombinant Proteins Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Strategies Deployed in Recombinant Proteins Market

Chapter 4. Global Recombinant Proteins Market by Product
4.1 Global Growth Factors & Chemokines Market by Region
4.2 Global Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors Market by Region
4.3 Global Structural Proteins Market by Region
4.4 Global Membrane Proteins Market by Region
4.5 Global Kinase Proteins & Regulatory Proteins Market by Region
4.6 Global Immune Response Proteins Market by Region
4.7 Global Others Market by Region

Chapter 5. Global Recombinant Proteins Market by End User
5.1 Global Pharmaceutical & Biopharmaceutical Companies Market by Region
5.2 Global Biotechnology Companies Market by Region
5.3 Global Academic Research Institutes Market by Region
5.4 Global Contract Research Organizations Market by Region

5.5 Global Others Market by Region
Chapter 6. Global Recombinant Proteins Market by Application
6.1 Global Drug Discovery & Development Market by Region
6.2 Global Academic Research Studies Market by Region
6.3 Global Biopharmaceutical Production Market by Region
6.4 Global Diagnostics Market by Region
6.5 Global Biotechnology Research Market by Region
6.6 Global Others Market by Region

Chapter 7. Global Recombinant Proteins Market by Region
7.1 North America Recombinant Proteins Market
7.1.1 North America Recombinant Proteins Market by Product
7.1.1.1 North America Growth Factors & Chemokines Market by Country
7.1.1.2 North America Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors Market by Country
7.1.1.3 North America Structural Proteins Market by Country
7.1.1.4 North America Membrane Proteins Market by Country
7.1.1.5 North America Kinase Proteins & Regulatory Proteins Market by Country
7.1.1.6 North America Immune Response Proteins Market by Country
7.1.1.7 North America Others Market by Country
7.1.2 North America Recombinant Proteins Market by End User
7.1.2.1 North America Pharmaceutical & Biopharmaceutical Companies Market by Country
7.1.2.2 North America Biotechnology Companies Market by Country
7.1.2.3 North America Academic Research Institutes Market by Country
7.1.2.4 North America Contract Research Organizations Market by Country
7.1.2.5 North America Others Market by Country
7.1.3 North America Recombinant Proteins Market by Application
7.1.3.1 North America Drug Discovery & Development Market by Country
7.1.3.2 North America Academic Research Studies Market by Country
7.1.3.3 North America Biopharmaceutical Production Market by Country
7.1.3.4 North America Diagnostics Market by Country
7.1.3.5 North America Biotechnology Research Market by Country
7.1.3.6 North America Others Market by Country
7.1.4 North America Recombinant Proteins Market by Country
7.1.4.1 US Recombinant Proteins Market
7.1.4.1.1 US Recombinant Proteins Market by Product
7.1.4.1.2 US Recombinant Proteins Market by End User
7.1.4.1.3 US Recombinant Proteins Market by Application
7.1.4.2 Canada Recombinant Proteins Market
7.1.4.2.1 Canada Recombinant Proteins Market by Product
7.1.4.2.2 Canada Recombinant Proteins Market by End User
7.1.4.2.3 Canada Recombinant Proteins Market by Application
7.1.4.3 Mexico Recombinant Proteins Market
7.1.4.3.1 Mexico Recombinant Proteins Market by Product
7.1.4.3.2 Mexico Recombinant Proteins Market by End User
7.1.4.3.3 Mexico Recombinant Proteins Market by Application
7.1.4.4 Rest of North America Recombinant Proteins Market
7.1.4.4.1 Rest of North America Recombinant Proteins Market by Product
7.1.4.4.2 Rest of North America Recombinant Proteins Market by End User
7.1.4.4.3 Rest of North America Recombinant Proteins Market by Application
7.2 Europe Recombinant Proteins Market
7.2.1 Europe Recombinant Proteins Market by Product
7.2.1.1 Europe Growth Factors & Chemokines Market by Country
7.2.1.2 Europe Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors Market by Country
7.2.1.3 Europe Structural Proteins Market by Country
7.2.1.4 Europe Membrane Proteins Market by Country
7.2.1.5 Europe Kinase Proteins & Regulatory Proteins Market by Country
7.2.1.6 Europe Immune Response Proteins Market by Country
7.2.1.7 Europe Others Market by Country
7.2.2 Europe Recombinant Proteins Market by End User
7.2.2.1 Europe Pharmaceutical & Biopharmaceutical Companies Market by Country
7.2.2.2 Europe Biotechnology Companies Market by Country
7.2.2.3 Europe Academic Research Institutes Market by Country
7.2.2.4 Europe Contract Research Organizations Market by Country
7.2.2.5 Europe Others Market by Country
7.2.3 Europe Recombinant Proteins Market by Application
7.2.3.1 Europe Drug Discovery & Development Market by Country
7.2.3.2 Europe Academic Research Studies Market by Country
7.2.3.3 Europe Biopharmaceutical Production Market by Country
7.2.3.4 Europe Diagnostics Market by Country
7.2.3.5 Europe Biotechnology Research Market by Country
7.2.3.6 Europe Others Market by Country
7.2.4 Europe Recombinant Proteins Market by Country
7.2.4.1 Germany Recombinant Proteins Market
7.2.4.1.1 Germany Recombinant Proteins Market by Product
7.2.4.1.2 Germany Recombinant Proteins Market by End User
7.2.4.1.3 Germany Recombinant Proteins Market by Application
7.2.4.2 UK Recombinant Proteins Market
7.2.4.2.1 UK Recombinant Proteins Market by Product
7.2.4.2.2 UK Recombinant Proteins Market by End User
7.2.4.2.3 UK Recombinant Proteins Market by Application
7.2.4.3 France Recombinant Proteins Market
7.2.4.3.1 France Recombinant Proteins Market by Product
7.2.4.3.2 France Recombinant Proteins Market by End User
7.2.4.3.3 France Recombinant Proteins Market by Application
7.2.4.4 Russia Recombinant Proteins Market
7.2.4.4.1 Russia Recombinant Proteins Market by Product
7.2.4.4.2 Russia Recombinant Proteins Market by End User
7.2.4.4.3 Russia Recombinant Proteins Market by Application
7.2.4.5 Spain Recombinant Proteins Market
7.2.4.5.1 Spain Recombinant Proteins Market by Product
7.2.4.5.2 Spain Recombinant Proteins Market by End User
7.2.4.5.3 Spain Recombinant Proteins Market by Application
7.2.4.6 Italy Recombinant Proteins Market
7.2.4.6.1 Italy Recombinant Proteins Market by Product
7.2.4.6.2 Italy Recombinant Proteins Market by End User
7.2.4.6.3 Italy Recombinant Proteins Market by Application
7.2.4.7 Rest of Europe Recombinant Proteins Market
7.2.4.7.1 Rest of Europe Recombinant Proteins Market by Product
7.2.4.7.2 Rest of Europe Recombinant Proteins Market by End User
7.2.4.7.3 Rest of Europe Recombinant Proteins Market by Application
7.3 Asia Pacific Recombinant Proteins Market
7.3.1 Asia Pacific Recombinant Proteins Market by Product
7.3.1.1 Asia Pacific Growth Factors & Chemokines Market by Country
7.3.1.2 Asia Pacific Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors Market by Country
7.3.1.3 Asia Pacific Structural Proteins Market by Country
7.3.1.4 Asia Pacific Membrane Proteins Market by Country
7.3.1.5 Asia Pacific Kinase Proteins & Regulatory Proteins Market by Country
7.3.1.6 Asia Pacific Immune Response Proteins Market by Country
7.3.1.7 Asia Pacific Others Market by Country
7.3.2 Asia Pacific Recombinant Proteins Market by End User
7.3.2.1 Asia Pacific Pharmaceutical & Biopharmaceutical Companies Market by Country
7.3.2.2 Asia Pacific Biotechnology Companies Market by Country
7.3.2.3 Asia Pacific Academic Research Institutes Market by Country
7.3.2.4 Asia Pacific Contract Research Organizations Market by Country
7.3.2.5 Asia Pacific Others Market by Country
7.3.3 Asia Pacific Recombinant Proteins Market by Application
7.3.3.1 Asia Pacific Drug Discovery & Development Market by Country
7.3.3.2 Asia Pacific Academic Research Studies Market by Country
7.3.3.3 Asia Pacific Biopharmaceutical Production Market by Country
7.3.3.4 Asia Pacific Diagnostics Market by Country
7.3.3.5 Asia Pacific Biotechnology Research Market by Country
7.3.3.6 Asia Pacific Others Market by Country
7.3.4 Asia Pacific Recombinant Proteins Market by Country
7.3.4.1 China Recombinant Proteins Market
7.3.4.1.1 China Recombinant Proteins Market by Product
7.3.4.1.2 China Recombinant Proteins Market by End User
7.3.4.1.3 China Recombinant Proteins Market by Application
7.3.4.2 Japan Recombinant Proteins Market
7.3.4.2.1 Japan Recombinant Proteins Market by Product
7.3.4.2.2 Japan Recombinant Proteins Market by End User
7.3.4.2.3 Japan Recombinant Proteins Market by Application
7.3.4.3 India Recombinant Proteins Market
7.3.4.3.1 India Recombinant Proteins Market by Product
7.3.4.3.2 India Recombinant Proteins Market by End User
7.3.4.3.3 India Recombinant Proteins Market by Application
7.3.4.4 South Korea Recombinant Proteins Market
7.3.4.4.1 South Korea Recombinant Proteins Market by Product
7.3.4.4.2 South Korea Recombinant Proteins Market by End User
7.3.4.4.3 South Korea Recombinant Proteins Market by Application
7.3.4.5 Singapore Recombinant Proteins Market
7.3.4.5.1 Singapore Recombinant Proteins Market by Product
7.3.4.5.2 Singapore Recombinant Proteins Market by End User
7.3.4.5.3 Singapore Recombinant Proteins Market by Application
7.3.4.6 Malaysia Recombinant Proteins Market
7.3.4.6.1 Malaysia Recombinant Proteins Market by Product
7.3.4.6.2 Malaysia Recombinant Proteins Market by End User
7.3.4.6.3 Malaysia Recombinant Proteins Market by Application
7.3.4.7 Rest of Asia Pacific Recombinant Proteins Market
7.3.4.7.1 Rest of Asia Pacific Recombinant Proteins Market by Product
7.3.4.7.2 Rest of Asia Pacific Recombinant Proteins Market by End User
7.3.4.7.3 Rest of Asia Pacific Recombinant Proteins Market by Application
7.4 LAMEA Recombinant Proteins Market
7.4.1 LAMEA Recombinant Proteins Market by Product
7.4.1.1 LAMEA Growth Factors & Chemokines Market by Country
7.4.1.2 LAMEA Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors Market by Country
7.4.1.3 LAMEA Structural Proteins Market by Country
7.4.1.4 LAMEA Membrane Proteins Market by Country
7.4.1.5 LAMEA Kinase Proteins & Regulatory Proteins Market by Country
7.4.1.6 LAMEA Immune Response Proteins Market by Country
7.4.1.7 LAMEA Others Market by Country
7.4.2 LAMEA Recombinant Proteins Market by End User
7.4.2.1 LAMEA Pharmaceutical & Biopharmaceutical Companies Market by Country
7.4.2.2 LAMEA Biotechnology Companies Market by Country
7.4.2.3 LAMEA Academic Research Institutes Market by Country
7.4.2.4 LAMEA Contract Research Organizations Market by Country
7.4.2.5 LAMEA Others Market by Country
7.4.3 LAMEA Recombinant Proteins Market by Application
7.4.3.1 LAMEA Drug Discovery & Development Market by Country
7.4.3.2 LAMEA Academic Research Studies Market by Country
7.4.3.3 LAMEA Biopharmaceutical Production Market by Country
7.4.3.4 LAMEA Diagnostics Market by Country
7.4.3.5 LAMEA Biotechnology Research Market by Country
7.4.3.6 LAMEA Others Market by Country
7.4.4 LAMEA Recombinant Proteins Market by Country
7.4.4.1 Brazil Recombinant Proteins Market
7.4.4.1.1 Brazil Recombinant Proteins Market by Product
7.4.4.1.2 Brazil Recombinant Proteins Market by End User
7.4.4.1.3 Brazil Recombinant Proteins Market by Application
7.4.4.2 Argentina Recombinant Proteins Market
7.4.4.2.1 Argentina Recombinant Proteins Market by Product
7.4.4.2.2 Argentina Recombinant Proteins Market by End User
7.4.4.2.3 Argentina Recombinant Proteins Market by Application
7.4.4.3 UAE Recombinant Proteins Market
7.4.4.3.1 UAE Recombinant Proteins Market by Product
7.4.4.3.2 UAE Recombinant Proteins Market by End User
7.4.4.3.3 UAE Recombinant Proteins Market by Application
7.4.4.4 Saudi Arabia Recombinant Proteins Market
7.4.4.4.1 Saudi Arabia Recombinant Proteins Market by Product
7.4.4.4.2 Saudi Arabia Recombinant Proteins Market by End User
7.4.4.4.3 Saudi Arabia Recombinant Proteins Market by Application
7.4.4.5 South Africa Recombinant Proteins Market
7.4.4.5.1 South Africa Recombinant Proteins Market by Product
7.4.4.5.2 South Africa Recombinant Proteins Market by End User
7.4.4.5.3 South Africa Recombinant Proteins Market by Application
7.4.4.6 Nigeria Recombinant Proteins Market
7.4.4.6.1 Nigeria Recombinant Proteins Market by Product
7.4.4.6.2 Nigeria Recombinant Proteins Market by End User
7.4.4.6.3 Nigeria Recombinant Proteins Market by Application
7.4.4.7 Rest of LAMEA Recombinant Proteins Market
7.4.4.7.1 Rest of LAMEA Recombinant Proteins Market by Product
7.4.4.7.2 Rest of LAMEA Recombinant Proteins Market by End User
7.4.4.7.3 Rest of LAMEA Recombinant Proteins Market by Application

Chapter 8. Company Profiles
8.1 Bio-Techne Corporation
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Product Launches and Product Expansions:
8.2 Thermo Fisher Scientific, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Acquisition and Mergers:
8.3 Merck Group
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.4 Bio-Rad laboratories, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Product Launches and Product Expansions:
8.5 Abcam plc
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.6 Genscript Biotech Corporation
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional & Segmental Analysis
8.6.4 Research & Development Expenses
8.7 Miltenyi Biotech B.V. & Co. KG
8.7.1 Company Overview
8.8 Proteintech Group, Inc.
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Acquisition and Mergers:
8.9 BPS Bioscience, Inc.
8.9.1 Company Overview
8.10. RayBiotech Life, Inc.
8.10.1 Company Overview

TABLE 1 Global Recombinant Proteins Market, 2018 - 2021, USD Million
TABLE 2 Global Recombinant Proteins Market, 2022 - 2028, USD Million
TABLE 3 Global Recombinant Proteins Market by Product, 2018 - 2021, USD Million
TABLE 4 Global Recombinant Proteins Market by Product, 2022 - 2028, USD Million
TABLE 5 Global Growth Factors & Chemokines Market by Region, 2018 - 2021, USD Million
TABLE 6 Global Growth Factors & Chemokines Market by Region, 2022 - 2028, USD Million
TABLE 7 Global Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors Market by Region, 2018 - 2021, USD Million
TABLE 8 Global Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors Market by Region, 2022 - 2028, USD Million
TABLE 9 Global Structural Proteins Market by Region, 2018 - 2021, USD Million
TABLE 10 Global Structural Proteins Market by Region, 2022 - 2028, USD Million
TABLE 11 Global Membrane Proteins Market by Region, 2018 - 2021, USD Million
TABLE 12 Global Membrane Proteins Market by Region, 2022 - 2028, USD Million
TABLE 13 Global Kinase Proteins & Regulatory Proteins Market by Region, 2018 - 2021, USD Million
TABLE 14 Global Kinase Proteins & Regulatory Proteins Market by Region, 2022 - 2028, USD Million
TABLE 15 Global Immune Response Proteins Market by Region, 2018 - 2021, USD Million
TABLE 16 Global Immune Response Proteins Market by Region, 2022 - 2028, USD Million
TABLE 17 Global Others Market by Region, 2018 - 2021, USD Million
TABLE 18 Global Others Market by Region, 2022 - 2028, USD Million
TABLE 19 Global Recombinant Proteins Market by End User, 2018 - 2021, USD Million
TABLE 20 Global Recombinant Proteins Market by End User, 2022 - 2028, USD Million
TABLE 21 Global Pharmaceutical & Biopharmaceutical Companies Market by Region, 2018 - 2021, USD Million
TABLE 22 Global Pharmaceutical & Biopharmaceutical Companies Market by Region, 2022 - 2028, USD Million
TABLE 23 Global Biotechnology Companies Market by Region, 2018 - 2021, USD Million
TABLE 24 Global Biotechnology Companies Market by Region, 2022 - 2028, USD Million
TABLE 25 Global Academic Research Institutes Market by Region, 2018 - 2021, USD Million
TABLE 26 Global Academic Research Institutes Market by Region, 2022 - 2028, USD Million
TABLE 27 Global Contract Research Organizations Market by Region, 2018 - 2021, USD Million
TABLE 28 Global Contract Research Organizations Market by Region, 2022 - 2028, USD Million
TABLE 29 Global Others Market by Region, 2018 - 2021, USD Million
TABLE 30 Global Others Market by Region, 2022 - 2028, USD Million
TABLE 31 Global Recombinant Proteins Market by Application, 2018 - 2021, USD Million
TABLE 32 Global Recombinant Proteins Market by Application, 2022 - 2028, USD Million
TABLE 33 Global Drug Discovery & Development Market by Region, 2018 - 2021, USD Million
TABLE 34 Global Drug Discovery & Development Market by Region, 2022 - 2028, USD Million
TABLE 35 Global Academic Research Studies Market by Region, 2018 - 2021, USD Million
TABLE 36 Global Academic Research Studies Market by Region, 2022 - 2028, USD Million
TABLE 37 Global Biopharmaceutical Production Market by Region, 2018 - 2021, USD Million
TABLE 38 Global Biopharmaceutical Production Market by Region, 2022 - 2028, USD Million
TABLE 39 Global Diagnostics Market by Region, 2018 - 2021, USD Million
TABLE 40 Global Diagnostics Market by Region, 2022 - 2028, USD Million
TABLE 41 Global Biotechnology Research Market by Region, 2018 - 2021, USD Million
TABLE 42 Global Biotechnology Research Market by Region, 2022 - 2028, USD Million
TABLE 43 Global Others Market by Region, 2018 - 2021, USD Million
TABLE 44 Global Others Market by Region, 2022 - 2028, USD Million
TABLE 45 Global Recombinant Proteins Market by Region, 2018 - 2021, USD Million
TABLE 46 Global Recombinant Proteins Market by Region, 2022 - 2028, USD Million
TABLE 47 North America Recombinant Proteins Market, 2018 - 2021, USD Million
TABLE 48 North America Recombinant Proteins Market, 2022 - 2028, USD Million
TABLE 49 North America Recombinant Proteins Market by Product, 2018 - 2021, USD Million
TABLE 50 North America Recombinant Proteins Market by Product, 2022 - 2028, USD Million
TABLE 51 North America Growth Factors & Chemokines Market by Country, 2018 - 2021, USD Million
TABLE 52 North America Growth Factors & Chemokines Market by Country, 2022 - 2028, USD Million
TABLE 53 North America Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors Market by Country, 2018 - 2021, USD Million
TABLE 54 North America Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors Market by Country, 2022 - 2028, USD Million
TABLE 55 North America Structural Proteins Market by Country, 2018 - 2021, USD Million
TABLE 56 North America Structural Proteins Market by Country, 2022 - 2028, USD Million
TABLE 57 North America Membrane Proteins Market by Country, 2018 - 2021, USD Million
TABLE 58 North America Membrane Proteins Market by Country, 2022 - 2028, USD Million
TABLE 59 North America Kinase Proteins & Regulatory Proteins Market by Country, 2018 - 2021, USD Million
TABLE 60 North America Kinase Proteins & Regulatory Proteins Market by Country, 2022 - 2028, USD Million
TABLE 61 North America Immune Response Proteins Market by Country, 2018 - 2021, USD Million
TABLE 62 North America Immune Response Proteins Market by Country, 2022 - 2028, USD Million
TABLE 63 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 64 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 65 North America Recombinant Proteins Market by End User, 2018 - 2021, USD Million
TABLE 66 North America Recombinant Proteins Market by End User, 2022 - 2028, USD Million
TABLE 67 North America Pharmaceutical & Biopharmaceutical Companies Market by Country, 2018 - 2021, USD Million
TABLE 68 North America Pharmaceutical & Biopharmaceutical Companies Market by Country, 2022 - 2028, USD Million
TABLE 69 North America Biotechnology Companies Market by Country, 2018 - 2021, USD Million
TABLE 70 North America Biotechnology Companies Market by Country, 2022 - 2028, USD Million
TABLE 71 North America Academic Research Institutes Market by Country, 2018 - 2021, USD Million
TABLE 72 North America Academic Research Institutes Market by Country, 2022 - 2028, USD Million
TABLE 73 North America Contract Research Organizations Market by Country, 2018 - 2021, USD Million
TABLE 74 North America Contract Research Organizations Market by Country, 2022 - 2028, USD Million
TABLE 75 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 76 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 77 North America Recombinant Proteins Market by Application, 2018 - 2021, USD Million
TABLE 78 North America Recombinant Proteins Market by Application, 2022 - 2028, USD Million
TABLE 79 North America Drug Discovery & Development Market by Country, 2018 - 2021, USD Million
TABLE 80 North America Drug Discovery & Development Market by Country, 2022 - 2028, USD Million
TABLE 81 North America Academic Research Studies Market by Country, 2018 - 2021, USD Million
TABLE 82 North America Academic Research Studies Market by Country, 2022 - 2028, USD Million
TABLE 83 North America Biopharmaceutical Production Market by Country, 2018 - 2021, USD Million
TABLE 84 North America Biopharmaceutical Production Market by Country, 2022 - 2028, USD Million
TABLE 85 North America Diagnostics Market by Country, 2018 - 2021, USD Million
TABLE 86 North America Diagnostics Market by Country, 2022 - 2028, USD Million
TABLE 87 North America Biotechnology Research Market by Country, 2018 - 2021, USD Million
TABLE 88 North America Biotechnology Research Market by Country, 2022 - 2028, USD Million
TABLE 89 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 90 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 91 North America Recombinant Proteins Market by Country, 2018 - 2021, USD Million
TABLE 92 North America Recombinant Proteins Market by Country, 2022 - 2028, USD Million
TABLE 93 US Recombinant Proteins Market, 2018 - 2021, USD Million
TABLE 94 US Recombinant Proteins Market, 2022 - 2028, USD Million
TABLE 95 US Recombinant Proteins Market by Product, 2018 - 2021, USD Million
TABLE 96 US Recombinant Proteins Market by Product, 2022 - 2028, USD Million
TABLE 97 US Recombinant Proteins Market by End User, 2018 - 2021, USD Million
TABLE 98 US Recombinant Proteins Market by End User, 2022 - 2028, USD Million
TABLE 99 US Recombinant Proteins Market by Application, 2018 - 2021, USD Million
TABLE 100 US Recombinant Proteins Market by Application, 2022 - 2028, USD Million
TABLE 101 Canada Recombinant Proteins Market, 2018 - 2021, USD Million
TABLE 102 Canada Recombinant Proteins Market, 2022 - 2028, USD Million
TABLE 103 Canada Recombinant Proteins Market by Product, 2018 - 2021, USD Million
TABLE 104 Canada Recombinant Proteins Market by Product, 2022 - 2028, USD Million
TABLE 105 Canada Recombinant Proteins Market by End User, 2018 - 2021, USD Million
TABLE 106 Canada Recombinant Proteins Market by End User, 2022 - 2028, USD Million
TABLE 107 Canada Recombinant Proteins Market by Application, 2018 - 2021, USD Million
TABLE 108 Canada Recombinant Proteins Market by Application, 2022 - 2028, USD Million
TABLE 109 Mexico Recombinant Proteins Market, 2018 - 2021, USD Million
TABLE 110 Mexico Recombinant Proteins Market, 2022 - 2028, USD Million
TABLE 111 Mexico Recombinant Proteins Market by Product, 2018 - 2021, USD Million
TABLE 112 Mexico Recombinant Proteins Market by Product, 2022 - 2028, USD Million
TABLE 113 Mexico Recombinant Proteins Market by End User, 2018 - 2021, USD Million
TABLE 114 Mexico Recombinant Proteins Market by End User, 2022 - 2028, USD Million
TABLE 115 Mexico Recombinant Proteins Market by Application, 2018 - 2021, USD Million
TABLE 116 Mexico Recombinant Proteins Market by Application, 2022 - 2028, USD Million
TABLE 117 Rest of North America Recombinant Proteins Market, 2018 - 2021, USD Million
TABLE 118 Rest of North America Recombinant Proteins Market, 2022 - 2028, USD Million
TABLE 119 Rest of North America Recombinant Proteins Market by Product, 2018 - 2021, USD Million
TABLE 120 Rest of North America Recombinant Proteins Market by Product, 2022 - 2028, USD Million
TABLE 121 Rest of North America Recombinant Proteins Market by End User, 2018 - 2021, USD Million
TABLE 122 Rest of North America Recombinant Proteins Market by End User, 2022 - 2028, USD Million
TABLE 123 Rest of North America Recombinant Proteins Market by Application, 2018 - 2021, USD Million
TABLE 124 Rest of North America Recombinant Proteins Market by Application, 2022 - 2028, USD Million
TABLE 125 Europe Recombinant Proteins Market, 2018 - 2021, USD Million
TABLE 126 Europe Recombinant Proteins Market, 2022 - 2028, USD Million
TABLE 127 Europe Recombinant Proteins Market by Product, 2018 - 2021, USD Million
TABLE 128 Europe Recombinant Proteins Market by Product, 2022 - 2028, USD Million
TABLE 129 Europe Growth Factors & Chemokines Market by Country, 2018 - 2021, USD Million
TABLE 130 Europe Growth Factors & Chemokines Market by Country, 2022 - 2028, USD Million
TABLE 131 Europe Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors Market by Country, 2018 - 2021, USD Million
TABLE 132 Europe Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors Market by Country, 2022 - 2028, USD Million
TABLE 133 Europe Structural Proteins Market by Country, 2018 - 2021, USD Million
TABLE 134 Europe Structural Proteins Market by Country, 2022 - 2028, USD Million
TABLE 135 Europe Membrane Proteins Market by Country, 2018 - 2021, USD Million
TABLE 136 Europe Membrane Proteins Market by Country, 2022 - 2028, USD Million
TABLE 137 Europe Kinase Proteins & Regulatory Proteins Market by Country, 2018 - 2021, USD Million
TABLE 138 Europe Kinase Proteins & Regulatory Proteins Market by Country, 2022 - 2028, USD Million
TABLE 139 Europe Immune Response Proteins Market by Country, 2018 - 2021, USD Million
TABLE 140 Europe Immune Response Proteins Market by Country, 2022 - 2028, USD Million
TABLE 141 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 142 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 143 Europe Recombinant Proteins Market by End User, 2018 - 2021, USD Million
TABLE 144 Europe Recombinant Proteins Market by End User, 2022 - 2028, USD Million
TABLE 145 Europe Pharmaceutical & Biopharmaceutical Companies Market by Country, 2018 - 2021, USD Million
TABLE 146 Europe Pharmaceutical & Biopharmaceutical Companies Market by Country, 2022 - 2028, USD Million
TABLE 147 Europe Biotechnology Companies Market by Country, 2018 - 2021, USD Million
TABLE 148 Europe Biotechnology Companies Market by Country, 2022 - 2028, USD Million
TABLE 149 Europe Academic Research Institutes Market by Country, 2018 - 2021, USD Million
TABLE 150 Europe Academic Research Institutes Market by Country, 2022 - 2028, USD Million
TABLE 151 Europe Contract Research Organizations Market by Country, 2018 - 2021, USD Million
TABLE 152 Europe Contract Research Organizations Market by Country, 2022 - 2028, USD Million
TABLE 153 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 154 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 155 Europe Recombinant Proteins Market by Application, 2018 - 2021, USD Million
TABLE 156 Europe Recombinant Proteins Market by Application, 2022 - 2028, USD Million
TABLE 157 Europe Drug Discovery & Development Market by Country, 2018 - 2021, USD Million
TABLE 158 Europe Drug Discovery & Development Market by Country, 2022 - 2028, USD Million
TABLE 159 Europe Academic Research Studies Market by Country, 2018 - 2021, USD Million
TABLE 160 Europe Academic Research Studies Market by Country, 2022 - 2028, USD Million
TABLE 161 Europe Biopharmaceutical Production Market by Country, 2018 - 2021, USD Million
TABLE 162 Europe Biopharmaceutical Production Market by Country, 2022 - 2028, USD Million
TABLE 163 Europe Diagnostics Market by Country, 2018 - 2021, USD Million
TABLE 164 Europe Diagnostics Market by Country, 2022 - 2028, USD Million
TABLE 165 Europe Biotechnology Research Market by Country, 2018 - 2021, USD Million
TABLE 166 Europe Biotechnology Research Market by Country, 2022 - 2028, USD Million
TABLE 167 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 168 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 169 Europe Recombinant Proteins Market by Country, 2018 - 2021, USD Million
TABLE 170 Europe Recombinant Proteins Market by Country, 2022 - 2028, USD Million
TABLE 171 Germany Recombinant Proteins Market, 2018 - 2021, USD Million
TABLE 172 Germany Recombinant Proteins Market, 2022 - 2028, USD Million
TABLE 173 Germany Recombinant Proteins Market by Product, 2018 - 2021, USD Million
TABLE 174 Germany Recombinant Proteins Market by Product, 2022 - 2028, USD Million
TABLE 175 Germany Recombinant Proteins Market by End User, 2018 - 2021, USD Million
TABLE 176 Germany Recombinant Proteins Market by End User, 2022 - 2028, USD Million
TABLE 177 Germany Recombinant Proteins Market by Application, 2018 - 2021, USD Million
TABLE 178 Germany Recombinant Proteins Market by Application, 2022 - 2028, USD Million
TABLE 179 UK Recombinant Proteins Market, 2018 - 2021, USD Million
TABLE 180 UK Recombinant Proteins Market, 2022 - 2028, USD Million
TABLE 181 UK Recombinant Proteins Market by Product, 2018 - 2021, USD Million
TABLE 182 UK Recombinant Proteins Market by Product, 2022 - 2028, USD Million
TABLE 183 UK Recombinant Proteins Market by End User, 2018 - 2021, USD Million
TABLE 184 UK Recombinant Proteins Market by End User, 2022 - 2028, USD Million
TABLE 185 UK Recombinant Proteins Market by Application, 2018 - 2021, USD Million
TABLE 186 UK Recombinant Proteins Market by Application, 2022 - 2028, USD Million
TABLE 187 France Recombinant Proteins Market, 2018 - 2021, USD Million
TABLE 188 France Recombinant Proteins Market, 2022 - 2028, USD Million
TABLE 189 France Recombinant Proteins Market by Product, 2018 - 2021, USD Million
TABLE 190 France Recombinant Proteins Market by Product, 2022 - 2028, USD Million
TABLE 191 France Recombinant Proteins Market by End User, 2018 - 2021, USD Million
TABLE 192 France Recombinant Proteins Market by End User, 2022 - 2028, USD Million
TABLE 193 France Recombinant Proteins Market by Application, 2018 - 2021, USD Million
TABLE 194 France Recombinant Proteins Market by Application, 2022 - 2028, USD Million
TABLE 195 Russia Recombinant Proteins Market, 2018 - 2021, USD Million
TABLE 196 Russia Recombinant Proteins Market, 2022 - 2028, USD Million
TABLE 197 Russia Recombinant Proteins Market by Product, 2018 - 2021, USD Million
TABLE 198 Russia Recombinant Proteins Market by Product, 2022 - 2028, USD Million
TABLE 199 Russia Recombinant Proteins Market by End User, 2018 - 2021, USD Million
TABLE 200 Russia Recombinant Proteins Market by End User, 2022 - 2028, USD Million
TABLE 201 Russia Recombinant Proteins Market by Application, 2018 - 2021, USD Million
TABLE 202 Russia Recombinant Proteins Market by Application, 2022 - 2028, USD Million
TABLE 203 Spain Recombinant Proteins Market, 2018 - 2021, USD Million
TABLE 204 Spain Recombinant Proteins Market, 2022 - 2028, USD Million
TABLE 205 Spain Recombinant Proteins Market by Product, 2018 - 2021, USD Million
TABLE 206 Spain Recombinant Proteins Market by Product, 2022 - 2028, USD Million
TABLE 207 Spain Recombinant Proteins Market by End User, 2018 - 2021, USD Million
TABLE 208 Spain Recombinant Proteins Market by End User, 2022 - 2028, USD Million
TABLE 209 Spain Recombinant Proteins Market by Application, 2018 - 2021, USD Million
TABLE 210 Spain Recombinant Proteins Market by Application, 2022 - 2028, USD Million
TABLE 211 Italy Recombinant Proteins Market, 2018 - 2021, USD Million
TABLE 212 Italy Recombinant Proteins Market, 2022 - 2028, USD Million
TABLE 213 Italy Recombinant Proteins Market by Product, 2018 - 2021, USD Million
TABLE 214 Italy Recombinant Proteins Market by Product, 2022 - 2028, USD Million
TABLE 215 Italy Recombinant Proteins Market by End User, 2018 - 2021, USD Million
TABLE 216 Italy Recombinant Proteins Market by End User, 2022 - 2028, USD Million
TABLE 217 Italy Recombinant Proteins Market by Application, 2018 - 2021, USD Million
TABLE 218 Italy Recombinant Proteins Market by Application, 2022 - 2028, USD Million
TABLE 219 Rest of Europe Recombinant Proteins Market, 2018 - 2021, USD Million
TABLE 220 Rest of Europe Recombinant Proteins Market, 2022 - 2028, USD Million
TABLE 221 Rest of Europe Recombinant Proteins Market by Product, 2018 - 2021, USD Million
TABLE 222 Rest of Europe Recombinant Proteins Market by Product, 2022 - 2028, USD Million
TABLE 223 Rest of Europe Recombinant Proteins Market by End User, 2018 - 2021, USD Million
TABLE 224 Rest of Europe Recombinant Proteins Market by End User, 2022 - 2028, USD Million
TABLE 225 Rest of Europe Recombinant Proteins Market by Application, 2018 - 2021, USD Million
TABLE 226 Rest of Europe Recombinant Proteins Market by Application, 2022 - 2028, USD Million
TABLE 227 Asia Pacific Recombinant Proteins Market, 2018 - 2021, USD Million
TABLE 228 Asia Pacific Recombinant Proteins Market, 2022 - 2028, USD Million
TABLE 229 Asia Pacific Recombinant Proteins Market by Product, 2018 - 2021, USD Million
TABLE 230 Asia Pacific Recombinant Proteins Market by Product, 2022 - 2028, USD Million
TABLE 231 Asia Pacific Growth Factors & Chemokines Market by Country, 2018 - 2021, USD Million
TABLE 232 Asia Pacific Growth Factors & Chemokines Market by Country, 2022 - 2028, USD Million
TABLE 233 Asia Pacific Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors Market by Country, 2018 - 2021, USD Million
TABLE 234 Asia Pacific Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors Market by Country, 2022 - 2028, USD Million
TABLE 235 Asia Pacific Structural Proteins Market by Country, 2018 - 2021, USD Million
TABLE 236 Asia Pacific Structural Proteins Market by Country, 2022 - 2028, USD Million
TABLE 237 Asia Pacific Membrane Proteins Market by Country, 2018 - 2021, USD Million
TABLE 238 Asia Pacific Membrane Proteins Market by Country, 2022 - 2028, USD Million
TABLE 239 Asia Pacific Kinase Proteins & Regulatory Proteins Market by Country, 2018 - 2021, USD Million
TABLE 240 Asia Pacific Kinase Proteins & Regulatory Proteins Market by Country, 2022 - 2028, USD Million
TABLE 241 Asia Pacific Immune Response Proteins Market by Country, 2018 - 2021, USD Million
TABLE 242 Asia Pacific Immune Response Proteins Market by Country, 2022 - 2028, USD Million
TABLE 243 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 244 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 245 Asia Pacific Recombinant Proteins Market by End User, 2018 - 2021, USD Million
TABLE 246 Asia Pacific Recombinant Proteins Market by End User, 2022 - 2028, USD Million
TABLE 247 Asia Pacific Pharmaceutical & Biopharmaceutical Companies Market by Country, 2018 - 2021, USD Million
TABLE 248 Asia Pacific Pharmaceutical & Biopharmaceutical Companies Market by Country, 2022 - 2028, USD Million
TABLE 249 Asia Pacific Biotechnology Companies Market by Country, 2018 - 2021, USD Million
TABLE 250 Asia Pacific Biotechnology Companies Market by Country, 2022 - 2028, USD Million
TABLE 251 Asia Pacific Academic Research Institutes Market by Country, 2018 - 2021, USD Million
TABLE 252 Asia Pacific Academic Research Institutes Market by Country, 2022 - 2028, USD Million
TABLE 253 Asia Pacific Contract Research Organizations Market by Country, 2018 - 2021, USD Million
TABLE 254 Asia Pacific Contract Research Organizations Market by Country, 2022 - 2028, USD Million
TABLE 255 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 256 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 257 Asia Pacific Recombinant Proteins Market by Application, 2018 - 2021, USD Million
TABLE 258 Asia Pacific Recombinant Proteins Market by Application, 2022 - 2028, USD Million
TABLE 259 Asia Pacific Drug Discovery & Development Market by Country, 2018 - 2021, USD Million
TABLE 260 Asia Pacific Drug Discovery & Development Market by Country, 2022 - 2028, USD Million
TABLE 261 Asia Pacific Academic Research Studies Market by Country, 2018 - 2021, USD Million
TABLE 262 Asia Pacific Academic Research Studies Market by Country, 2022 - 2028, USD Million
TABLE 263 Asia Pacific Biopharmaceutical Production Market by Country, 2018 - 2021, USD Million
TABLE 264 Asia Pacific Biopharmaceutical Production Market by Country, 2022 - 2028, USD Million
TABLE 265 Asia Pacific Diagnostics Market by Country, 2018 - 2021, USD Million
TABLE 266 Asia Pacific Diagnostics Market by Country, 2022 - 2028, USD Million
TABLE 267 Asia Pacific Biotechnology Research Market by Country, 2018 - 2021, USD Million
TABLE 268 Asia Pacific Biotechnology Research Market by Country, 2022 - 2028, USD Million
TABLE 269 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 270 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 271 Asia Pacific Recombinant Proteins Market by Country, 2018 - 2021, USD Million
TABLE 272 Asia Pacific Recombinant Proteins Market by Country, 2022 - 2028, USD Million
TABLE 273 China Recombinant Proteins Market, 2018 - 2021, USD Million
TABLE 274 China Recombinant Proteins Market, 2022 - 2028, USD Million
TABLE 275 China Recombinant Proteins Market by Product, 2018 - 2021, USD Million
TABLE 276 China Recombinant Proteins Market by Product, 2022 - 2028, USD Million
TABLE 277 China Recombinant Proteins Market by End User, 2018 - 2021, USD Million
TABLE 278 China Recombinant Proteins Market by End User, 2022 - 2028, USD Million
TABLE 279 China Recombinant Proteins Market by Application, 2018 - 2021, USD Million
TABLE 280 China Recombinant Proteins Market by Application, 2022 - 2028, USD Million
TABLE 281 Japan Recombinant Proteins Market, 2018 - 2021, USD Million
TABLE 282 Japan Recombinant Proteins Market, 2022 - 2028, USD Million
TABLE 283 Japan Recombinant Proteins Market by Product, 2018 - 2021, USD Million
TABLE 284 Japan Recombinant Proteins Market by Product, 2022 - 2028, USD Million
TABLE 285 Japan Recombinant Proteins Market by End User, 2018 - 2021, USD Million
TABLE 286 Japan Recombinant Proteins Market by End User, 2022 - 2028, USD Million
TABLE 287 Japan Recombinant Proteins Market by Application, 2018 - 2021, USD Million
TABLE 288 Japan Recombinant Proteins Market by Application, 2022 - 2028, USD Million
TABLE 289 India Recombinant Proteins Market, 2018 - 2021, USD Million
TABLE 290 India Recombinant Proteins Market, 2022 - 2028, USD Million
TABLE 291 India Recombinant Proteins Market by Product, 2018 - 2021, USD Million
TABLE 292 India Recombinant Proteins Market by Product, 2022 - 2028, USD Million
TABLE 293 India Recombinant Proteins Market by End User, 2018 - 2021, USD Million
TABLE 294 India Recombinant Proteins Market by End User, 2022 - 2028, USD Million
TABLE 295 India Recombinant Proteins Market by Application, 2018 - 2021, USD Million
TABLE 296 India Recombinant Proteins Market by Application, 2022 - 2028, USD Million
TABLE 297 South Korea Recombinant Proteins Market, 2018 - 2021, USD Million
TABLE 298 South Korea Recombinant Proteins Market, 2022 - 2028, USD Million
TABLE 299 South Korea Recombinant Proteins Market by Product, 2018 - 2021, USD Million
TABLE 300 South Korea Recombinant Proteins Market by Product, 2022 - 2028, USD Million
TABLE 301 South Korea Recombinant Proteins Market by End User, 2018 - 2021, USD Million
TABLE 302 South Korea Recombinant Proteins Market by End User, 2022 - 2028, USD Million
TABLE 303 South Korea Recombinant Proteins Market by Application, 2018 - 2021, USD Million
TABLE 304 South Korea Recombinant Proteins Market by Application, 2022 - 2028, USD Million
TABLE 305 Singapore Recombinant Proteins Market, 2018 - 2021, USD Million
TABLE 306 Singapore Recombinant Proteins Market, 2022 - 2028, USD Million
TABLE 307 Singapore Recombinant Proteins Market by Product, 2018 - 2021, USD Million
TABLE 308 Singapore Recombinant Proteins Market by Product, 2022 - 2028, USD Million
TABLE 309 Singapore Recombinant Proteins Market by End User, 2018 - 2021, USD Million
TABLE 310 Singapore Recombinant Proteins Market by End User, 2022 - 2028, USD Million
TABLE 311 Singapore Recombinant Proteins Market by Application, 2018 - 2021, USD Million
TABLE 312 Singapore Recombinant Proteins Market by Application, 2022 - 2028, USD Million
TABLE 313 Malaysia Recombinant Proteins Market, 2018 - 2021, USD Million
TABLE 314 Malaysia Recombinant Proteins Market, 2022 - 2028, USD Million
TABLE 315 Malaysia Recombinant Proteins Market by Product, 2018 - 2021, USD Million
TABLE 316 Malaysia Recombinant Proteins Market by Product, 2022 - 2028, USD Million
TABLE 317 Malaysia Recombinant Proteins Market by End User, 2018 - 2021, USD Million
TABLE 318 Malaysia Recombinant Proteins Market by End User, 2022 - 2028, USD Million
TABLE 319 Malaysia Recombinant Proteins Market by Application, 2018 - 2021, USD Million
TABLE 320 Malaysia Recombinant Proteins Market by Application, 2022 - 2028, USD Million
TABLE 321 Rest of Asia Pacific Recombinant Proteins Market, 2018 - 2021, USD Million
TABLE 322 Rest of Asia Pacific Recombinant Proteins Market, 2022 - 2028, USD Million
TABLE 323 Rest of Asia Pacific Recombinant Proteins Market by Product, 2018 - 2021, USD Million
TABLE 324 Rest of Asia Pacific Recombinant Proteins Market by Product, 2022 - 2028, USD Million
TABLE 325 Rest of Asia Pacific Recombinant Proteins Market by End User, 2018 - 2021, USD Million
TABLE 326 Rest of Asia Pacific Recombinant Proteins Market by End User, 2022 - 2028, USD Million
TABLE 327 Rest of Asia Pacific Recombinant Proteins Market by Application, 2018 - 2021, USD Million
TABLE 328 Rest of Asia Pacific Recombinant Proteins Market by Application, 2022 - 2028, USD Million
TABLE 329 LAMEA Recombinant Proteins Market, 2018 - 2021, USD Million
TABLE 330 LAMEA Recombinant Proteins Market, 2022 - 2028, USD Million
TABLE 331 LAMEA Recombinant Proteins Market by Product, 2018 - 2021, USD Million
TABLE 332 LAMEA Recombinant Proteins Market by Product, 2022 - 2028, USD Million
TABLE 333 LAMEA Growth Factors & Chemokines Market by Country, 2018 - 2021, USD Million
TABLE 334 LAMEA Growth Factors & Chemokines Market by Country, 2022 - 2028, USD Million
TABLE 335 LAMEA Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors Market by Country, 2018 - 2021, USD Million
TABLE 336 LAMEA Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors Market by Country, 2022 - 2028, USD Million
TABLE 337 LAMEA Structural Proteins Market by Country, 2018 - 2021, USD Million
TABLE 338 LAMEA Structural Proteins Market by Country, 2022 - 2028, USD Million
TABLE 339 LAMEA Membrane Proteins Market by Country, 2018 - 2021, USD Million
TABLE 340 LAMEA Membrane Proteins Market by Country, 2022 - 2028, USD Million
TABLE 341 LAMEA Kinase Proteins & Regulatory Proteins Market by Country, 2018 - 2021, USD Million
TABLE 342 LAMEA Kinase Proteins & Regulatory Proteins Market by Country, 2022 - 2028, USD Million
TABLE 343 LAMEA Immune Response Proteins Market by Country, 2018 - 2021, USD Million
TABLE 344 LAMEA Immune Response Proteins Market by Country, 2022 - 2028, USD Million
TABLE 345 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 346 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 347 LAMEA Recombinant Proteins Market by End User, 2018 - 2021, USD Million
TABLE 348 LAMEA Recombinant Proteins Market by End User, 2022 - 2028, USD Million
TABLE 349 LAMEA Pharmaceutical & Biopharmaceutical Companies Market by Country, 2018 - 2021, USD Million
TABLE 350 LAMEA Pharmaceutical & Biopharmaceutical Companies Market by Country, 2022 - 2028, USD Million
TABLE 351 LAMEA Biotechnology Companies Market by Country, 2018 - 2021, USD Million
TABLE 352 LAMEA Biotechnology Companies Market by Country, 2022 - 2028, USD Million
TABLE 353 LAMEA Academic Research Institutes Market by Country, 2018 - 2021, USD Million
TABLE 354 LAMEA Academic Research Institutes Market by Country, 2022 - 2028, USD Million
TABLE 355 LAMEA Contract Research Organizations Market by Country, 2018 - 2021, USD Million
TABLE 356 LAMEA Contract Research Organizations Market by Country, 2022 - 2028, USD Million
TABLE 357 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 358 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 359 LAMEA Recombinant Proteins Market by Application, 2018 - 2021, USD Million
TABLE 360 LAMEA Recombinant Proteins Market by Application, 2022 - 2028, USD Million
TABLE 361 LAMEA Drug Discovery & Development Market by Country, 2018 - 2021, USD Million
TABLE 362 LAMEA Drug Discovery & Development Market by Country, 2022 - 2028, USD Million
TABLE 363 LAMEA Academic Research Studies Market by Country, 2018 - 2021, USD Million
TABLE 364 LAMEA Academic Research Studies Market by Country, 2022 - 2028, USD Million
TABLE 365 LAMEA Biopharmaceutical Production Market by Country, 2018 - 2021, USD Million
TABLE 366 LAMEA Biopharmaceutical Production Market by Country, 2022 - 2028, USD Million
TABLE 367 LAMEA Diagnostics Market by Country, 2018 - 2021, USD Million
TABLE 368 LAMEA Diagnostics Market by Country, 2022 - 2028, USD Million
TABLE 369 LAMEA Biotechnology Research Market by Country, 2018 - 2021, USD Million
TABLE 370 LAMEA Biotechnology Research Market by Country, 2022 - 2028, USD Million
TABLE 371 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 372 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 373 LAMEA Recombinant Proteins Market by Country, 2018 - 2021, USD Million
TABLE 374 LAMEA Recombinant Proteins Market by Country, 2022 - 2028, USD Million
TABLE 375 Brazil Recombinant Proteins Market, 2018 - 2021, USD Million
TABLE 376 Brazil Recombinant Proteins Market, 2022 - 2028, USD Million
TABLE 377 Brazil Recombinant Proteins Market by Product, 2018 - 2021, USD Million
TABLE 378 Brazil Recombinant Proteins Market by Product, 2022 - 2028, USD Million
TABLE 379 Brazil Recombinant Proteins Market by End User, 2018 - 2021, USD Million
TABLE 380 Brazil Recombinant Proteins Market by End User, 2022 - 2028, USD Million
TABLE 381 Brazil Recombinant Proteins Market by Application, 2018 - 2021, USD Million
TABLE 382 Brazil Recombinant Proteins Market by Application, 2022 - 2028, USD Million
TABLE 383 Argentina Recombinant Proteins Market, 2018 - 2021, USD Million
TABLE 384 Argentina Recombinant Proteins Market, 2022 - 2028, USD Million
TABLE 385 Argentina Recombinant Proteins Market by Product, 2018 - 2021, USD Million
TABLE 386 Argentina Recombinant Proteins Market by Product, 2022 - 2028, USD Million
TABLE 387 Argentina Recombinant Proteins Market by End User, 2018 - 2021, USD Million
TABLE 388 Argentina Recombinant Proteins Market by End User, 2022 - 2028, USD Million
TABLE 389 Argentina Recombinant Proteins Market by Application, 2018 - 2021, USD Million
TABLE 390 Argentina Recombinant Proteins Market by Application, 2022 - 2028, USD Million
TABLE 391 UAE Recombinant Proteins Market, 2018 - 2021, USD Million
TABLE 392 UAE Recombinant Proteins Market, 2022 - 2028, USD Million
TABLE 393 UAE Recombinant Proteins Market by Product, 2018 - 2021, USD Million
TABLE 394 UAE Recombinant Proteins Market by Product, 2022 - 2028, USD Million
TABLE 395 UAE Recombinant Proteins Market by End User, 2018 - 2021, USD Million
TABLE 396 UAE Recombinant Proteins Market by End User, 2022 - 2028, USD Million
TABLE 397 UAE Recombinant Proteins Market by Application, 2018 - 2021, USD Million
TABLE 398 UAE Recombinant Proteins Market by Application, 2022 - 2028, USD Million
TABLE 399 Saudi Arabia Recombinant Proteins Market, 2018 - 2021, USD Million
TABLE 400 Saudi Arabia Recombinant Proteins Market, 2022 - 2028, USD Million